Suppr超能文献

同质且功能性人诱导多能干细胞来源的肝类器官的高通量生物工程微图案化技术。

High-throughput bioengineering of homogenous and functional human-induced pluripotent stem cells-derived liver organoids micropatterning technique.

作者信息

Xu Xiaodong, Jiang Shanqing, Gu Longjun, Li Bin, Xu Fang, Li Changyong, Chen Pu

机构信息

Tissue Engineering and Organ Manufacturing (TEOM) Lab, Department of Biomedical Engineering, Wuhan University TaiKang Medical School (School of Basic Medical Sciences), Wuhan, China.

Hubei Province Key Laboratory of Allergy and Immunology, Wuhan University TaiKang Medical School (School of Basic Medical Sciences), Wuhan, China.

出版信息

Front Bioeng Biotechnol. 2022 Aug 10;10:937595. doi: 10.3389/fbioe.2022.937595. eCollection 2022.

Abstract

Human pluripotent stem cell-derived liver organoids are emerging as more human-relevant models for studying liver diseases and hepatotoxicity than traditional hepatocyte cultures and animal models. The generation of liver organoids is based on the Matrigel dome method. However, the organoids constructed by this method display significant heterogeneity in their morphology, size, and maturity. Additionally, the formed organoid is randomly encapsulated in the Matrigel dome, which is not convenient for staining and imaging. Here, we demonstrate an approach to generate a novel type of liver organoids via micropatterning technique. This approach enables the reproducible and high-throughput formation of bioengineered fetal liver organoids with uniform morphology and deterministic size and location in a multiwell plate. The liver organoids constructed by this technique closely recapitulate some critical features of human liver development at the fetal stage, including fetal liver-specific gene and protein expression, glycogen storage, lipid accumulation, and protein secretion. Additionally, the organoids allow whole-mount staining and imaging. Overall, this new type of liver organoids is compatible with the pharmaceutical industry's widely-used preclinical drug discovery tools and will facilitate liver drug screening and hepatotoxic assessment.

摘要

与传统的肝细胞培养和动物模型相比,人多能干细胞衍生的肝脏类器官正成为研究肝脏疾病和肝毒性的更具人体相关性的模型。肝脏类器官的生成基于基质胶穹顶法。然而,用这种方法构建的类器官在形态、大小和成熟度方面表现出显著的异质性。此外,形成的类器官随机包裹在基质胶穹顶中,这不利于染色和成像。在此,我们展示了一种通过微图案化技术生成新型肝脏类器官的方法。这种方法能够在多孔板中以可重复且高通量的方式形成具有均匀形态、确定大小和位置的生物工程化胎儿肝脏类器官。通过该技术构建的肝脏类器官紧密再现了胎儿期人类肝脏发育的一些关键特征,包括胎儿肝脏特异性基因和蛋白质表达、糖原储存、脂质积累和蛋白质分泌。此外,这些类器官允许进行整体染色和成像。总体而言,这种新型肝脏类器官与制药行业广泛使用的临床前药物发现工具兼容,并将促进肝脏药物筛选和肝毒性评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ac/9399390/232125b8b2cf/fbioe-10-937595-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验